English

MAIO, 25
SÃO PAULO – SP - BRAZIL
(NOVOTEL MORUMBI)

PERFIL DOS PARTICIPANTES

Categorias de produtos

Branded generics: 37.5%
75

Biological products: 35.9%
71.8

Biosimilars: 26.6%
53.2

Hospital products: 31.3%
62.6

Innovative medicines: 51.6%
103.2

mais informações




Interesses estratégicos

In-licensing: 45.3%
90.6

Out-licensing: 32.8%
65.6

Co-marketing: 28.1%
56.2

Co-promotion: 29.7%
59.4

Co-development: 39.1%
78.2

mais informações




Área terapêutica

Cardiovascular: 45.3%
90.6

CNS: 54.7%
109.4

Infectious diseases: 34.4%
68.8

Pain: 46.9%
93.8

Respiratory: 31.3%
62.6

mais informações



PARTICIPANTES 2017

Allergy/immunology: 16.4%

Cardiovascular: 45.3%

CNS: 54.7%

Dentistry: 5.5%

Dermatology: 12.5%

Drug delivers technol.: 22.7%

Gastroenterology: 18.0%

Gerontology: 9.4%

Gynecology: 20.3%

Infectious diseases: 34.4%

Hematology: 14.6%

Ophthalmology: 10.9%

Oncology: 21.9%

Orthopedics: 12.5%

Pain: 46.9%

Pediatrics: 9.4%

Psychiatrics: 17.2%

Respiratory: 31.3%

Rheumatology: 15.6%

Urology: 11.7%

Vaccines: 7.8%

partner